EC approves expanded use of ustekinumab for ulcerative colitis
The biologic treatment ustekinumab has been granted an expanded use for ulcerative colitis within the EU.
List view / Grid view
The biologic treatment ustekinumab has been granted an expanded use for ulcerative colitis within the EU.
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
NICE has issued a recommendation for risankizumab to treat patients with severe plaque psoriasis.
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis...